Christelle Baunez, Ph.D - Related publications

Affiliations: 
Institut de Neurosciences de La Timone CNRS/Aix-Marseille University 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Farmer K, Abd-Elrahman KS, Derksen A, Rowe EM, Thompson AM, Rudyk CA, Prowse NA, Dwyer Z, Bureau SC, Fortin T, Ferguson SSG, Hayley S. mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease. Molecular Neurobiology. PMID 31754998 DOI: 10.1007/s12035-019-01818-z   
2019 Samoudi G, Nilsson A, Carlsson T, Bergquist F. c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats. Neuroscience. PMID 31704349 DOI: 10.1016/j.neuroscience.2019.10.039   
2019 Mishra A, Singh S, Tiwari V, Bano S, Shukla S. Dopamine Receptor D1 Agonism Induces Dynamin Related Protein-1 Inhibition to Improve Mitochondrial Biogenesis and Dopaminergic Neurogenesis in Rat Model of Parkinson's disease. Behavioural Brain Research. 112304. PMID 31626851 DOI: 10.1016/j.bbr.2019.112304   
2019 Elle T, Alam M, Voigt C, Krauss JK, John N, Schwabe K. Deep brain stimulation of the thalamic centromedian-parafascicular nucleus improves behavioural and neuronal traits in a rat model of Tourette. Behavioural Brain Research. 112251. PMID 31614188 DOI: 10.1016/j.bbr.2019.112251   
2019 Souza MF, Medeiros KAAL, Lins LCRF, Bispo JMM, Gois AM, Freire MAM, Marchioro M, Santos JR. Intracerebroventricular injection of deltamethrin increases locomotion activity and causes spatial working memory and dopaminergic pathway impairment in rats. Brain Research Bulletin. 154: 1-8. PMID 31606407 DOI: 10.1016/j.brainresbull.2019.10.002   
2019 Barbosa P, Hapuarachchi B, Djamshidian A, Strand K, Lees AJ, de Silva R, Holton JL, Warner TT. Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours. Brain : a Journal of Neurology. PMID 31603207 DOI: 10.1093/brain/awz298   
2019 Soto-Rojas LO, Garces-Ramirez L, Luna-Herrera C, Flores-Martinez JM, Soto-Rodriguez G, Gatica-Garcia B, Lopez-Salas FE, Ayala-Davila J, Gutierrez-Castillo ME, Padilla-Viveros A, Bañuelos C, de la Cruz-Lopez F, Martinez-Davila IA, Martinez-Fong D. A single intranigral administration of β-sitosterol β-d-glucoside elicits bilateral sensorimotor and non-motor alterations in the rat. Behavioural Brain Research. 112279. PMID 31606429 DOI: 10.1016/j.bbr.2019.112279   
2019 Barroso SDS, Lopes LES, Santos KS, Gomes MZ. Technological prospection: Patents mapping involving compounds for the treatment of L-DOPA-induced dyskinesias. Expert Opinion On Therapeutic Patents. PMID 31694421 DOI: 10.1080/13543776.2019.1690453   
2019 de Haas R, Heltzel LCMW, Tax D, van den Broek P, Steenbreker H, Verheij MMM, Russel FGM, Orr AL, Nakamura K, Smeitink JAM. To be or not to be pink(1): contradictory findings in an animal model for Parkinson's disease. Brain Communications. 1: fcz016. PMID 31667474 DOI: 10.1093/braincomms/fcz016   
2019 Yang P, Perlmutter JS, Benzinger TLS, Morris JC, Xu J. Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis and treatment? Ageing Research Reviews. 100994. PMID 31765822 DOI: 10.1016/j.arr.2019.100994   
2019 Vaz RL, Chapela D, Coelho JE, Lopes LV, Ferreira JJ, Afonso ND, Sousa S, Outeiro TF. Tapentadol Prevents Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience. PMID 31682948 DOI: 10.1016/j.neuroscience.2019.08.046   
2019 Floren S, King N, Carrasco A, Dafny N. Glutamate and dopamine in the VTA participate differently in the acute and chronic effect of methylphenidate. Behavioural Brain Research. 112390. PMID 31783089 DOI: 10.1016/j.bbr.2019.112390   
2019 Hunn BHM, Vingill S, Threlfell S, Alegre-Abarrategui J, Magdelyns M, Deltheil T, Bengoa-Vergniory N, Oliver PL, Cioroch M, Doig NM, Bannerman DM, Cragg SJ, Wade-Martins R. Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior. Cell Reports. 29: 920-931.e7. PMID 31644913 DOI: 10.1016/j.celrep.2019.09.029   
2019 Giangrasso DM, Furlong TM, Keefe KA. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease. Neurobiology of Disease. 104673. PMID 31734455 DOI: 10.1016/j.nbd.2019.104673   
2019 Soares C, Vilas-Boas MDC, Lopes EM, Choupina H, Soares-Dos-Reis R, Fitas D, Cunha JPS, Monteiro P, Linhares P, Rosas MJ. Automated and objective measures of gait dynamics in camptocormia Parkinson's Disease subthalamic deep brain stimulation. Clinical Neurology and Neurosurgery. 186: 105537. PMID 31605896 DOI: 10.1016/j.clineuro.2019.105537   
2019 Parkhe A, Parekh P, Nalla LV, Sharma N, Sharma M, Gadepalli A, Kate A, Khairnar A. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease. Neuroscience Letters. 134652. PMID 31778768 DOI: 10.1016/j.neulet.2019.134652   
2019 Zhu GY, Geng XY, Zhang RL, Chen YC, Liu YY, Wang SY, Zhang JG. Deep brain stimulation modulates pallidal and subthalamic neural oscillations in Tourette's syndrome. Brain and Behavior. e01450. PMID 31647199 DOI: 10.1002/brb3.1450   
2019 Fan SY, Wang KL, Hu W, Eisinger RS, Han A, Han CL, Wang Q, Michitomo S, Zhang JG, Wang F, Ramirez-Zamora A, Meng FG. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia. Annals of Clinical and Translational Neurology. PMID 31813194 DOI: 10.1002/acn3.50961   
2019 Roostalu U, Salinas CBG, Thorbek DD, Skytte JL, Fabricius K, Barkholt P, John LM, Jurtz VI, Knudsen LB, Jelsing J, Vrang N, Hansen HH, Hecksher-Sørensen J. Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labelled neuron architecture in the mouse MPTP model of Parkinson's disease. Disease Models & Mechanisms. PMID 31704726 DOI: 10.1242/dmm.042200   
2019 Kishimoto Y, Johnson J, Fang W, Halpern J, Marosi K, Liu D, Geisler JG, Mattson MP. A mitochondrial uncoupler prodrug protects dopaminergic neurons and improves functional outcome in a mouse model of Parkinson's disease. Neurobiology of Aging. PMID 31718928 DOI: 10.1016/j.neurobiolaging.2019.09.011   
2019 Pak ME, Ahn SM, Jung DH, Lee HJ, Ha KT, Shin HK, Choi BT. Electroacupuncture therapy ameliorates motor dysfunction via brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 31644786 DOI: 10.1093/gerona/glz256   
2019 Yu Y, Hao Y, Wang Q. Model-based optimized phase-deviation deep brain stimulation for Parkinson 's disease. Neural Networks : the Official Journal of the International Neural Network Society. 122: 308-319. PMID 31739269 DOI: 10.1016/j.neunet.2019.11.001   
2019 Kim HJ, Jeon B. Decision under risk: Argument against early deep brain stimulation in Parkinson's disease. Parkinsonism & Related Disorders. 69: 7-10. PMID 31634692 DOI: 10.1016/j.parkreldis.2019.10.008   
2019 Song IU, Na SH, Im JJ, Jeong H, Chung SW, Chung YA. Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease: Clinical and Regional Cerebral Blood Flow SPECT Outcomes. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 31762114 DOI: 10.1111/jon.12681   
2019 Tseng HC, Wang MH, Chang KC, Soung HS, Fang CH, Lin YW, Li KY, Yang CC, Tsai CC. Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats. Neurotoxicity Research. PMID 31811588 DOI: 10.1007/s12640-019-00143-6   
2019 Leta V, Jenner P, Chaudhuri KR, Antonini A. Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update. Expert Opinion On Drug Safety. PMID 31619083 DOI: 10.1080/14740338.2019.1681966   
2019 Moschovou K, Melagraki G, Mavromoustakos T, Zacharia LC, Afantitis A. Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson's disease therapeutics. Expert Opinion On Drug Discovery. 1-10. PMID 31744341 DOI: 10.1080/17460441.2020.1691165   
2019 Weng SJ, Chen CF, Huang YS, Chiu CH, Wu SC, Lin CY, Chueh SH, Cheng CY, Ma KH. Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model. Xenotransplantation. e12569. PMID 31777103 DOI: 10.1111/xen.12569   
2019 Marquis JM, Lettenberger SE, Kelm-Nelson CA. Early-onset Parkinsonian behaviors in female Pink1-/- rats. Behavioural Brain Research. 377: 112175. PMID 31542395 DOI: 10.1016/j.bbr.2019.112175   
2019 Mendes-Pinheiro B, Anjo SI, Manadas B, Da Silva JD, Marote A, Behie LA, Teixeira FG, Salgado AJ. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model. Frontiers in Bioengineering and Biotechnology. 7: 294. PMID 31737616 DOI: 10.3389/fbioe.2019.00294   
2019 Martin TA, Smith HR, Luessen DJ, Chen R, Porrino LJ. Functional Brain Activity Is Globally Elevated by Dopamine D2 Receptor Knockdown in the Ventral Tegmental Area. Brain Research. 146552. PMID 31726041 DOI: 10.1016/j.brainres.2019.146552   
2019 Georgiades MJ, Shine JM, Gilat M, McMaster J, Owler B, Mahant N, Lewis SJG. Hitting the brakes: pathological subthalamic nucleus activity in Parkinson's disease gait freezing. Brain : a Journal of Neurology. PMID 31665229 DOI: 10.1093/brain/awz325   
2019 Ling L, Jiang Y, Liu Y, Li H, Bari A, Ullah R, Xue J. Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model. Journal of Photochemistry and Photobiology. B, Biology. 201: 111657. PMID 31706085 DOI: 10.1016/j.jphotobiol.2019.111657   
2019 Gong S, Xu M, Tao Y, Liu Y, Jin H, Sun X, Wang S, Yang X, Wang Y, Yuan L, Song W. Comparison of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation Surgery on Parkinson's Disease-related Pain. World Neurosurgery. PMID 31733388 DOI: 10.1016/j.wneu.2019.11.026   
2019 Edwards Iii G, Gamez N, Armijo E, Kramm C, Morales R, Taylor-Presse K, Schulz PE, Soto C, Moreno-Gonzalez I. Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson's Disease-Associated Pathology. Cells. 8. PMID 31671704 DOI: 10.3390/cells8111359   
2019 Lim HS, Kim JS, Moon BC, Ryu SM, Lee J, Park G. Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage. Antioxidants (Basel, Switzerland). 8. PMID 31766449 DOI: 10.3390/antiox8120574   
2019 Mi TM, Garg S, Ba F, Liu AP, Wu T, Gao LL, Dan XJ, Chan P, McKeown MJ. High-frequency rTMS over the supplementary motor area improves freezing of gait in Parkinson's disease: a randomized controlled trial. Parkinsonism & Related Disorders. 68: 85-90. PMID 31689588 DOI: 10.1016/j.parkreldis.2019.10.009   
2019 Mosley RL, Lu Y, Olson KE, Machhi J, Yan W, Namminga KL, Smith JR, Shandler SJ, Gendelman HE. A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease. Frontiers in Cellular Neuroscience. 13: 421. PMID 31619964 DOI: 10.3389/fncel.2019.00421   
2019 Gárate-Pérez MF, Méndez A, Bahamondes C, Sanhueza C, Guzmán F, Reyes-Parada M, Sotomayor-Zárate R, Renard GM. Vasopressin in the lateral septum decreases conditioned place preference to amphetamine and nucleus accumbens dopamine release. Addiction Biology. e12851. PMID 31691406 DOI: 10.1111/adb.12851   
2019 Yoo HS, Choi YH, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia. Annals of Clinical and Translational Neurology. PMID 31643140 DOI: 10.1002/acn3.50918   
2019 Mishra A, Krishnamurthy S. Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson's disease. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 31654086 DOI: 10.1007/s00210-019-01737-9   
2019 Liu Q, Zhang S, Zhu D, Tang X, Che Y, Feng X. The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson's disease in mice. Behavioural Brain Research. 112337. PMID 31697983 DOI: 10.1016/j.bbr.2019.112337   
2019 Heredia M, Rodríguez N, Sánchez Robledo V, Criado JM, de la Fuente A, Devesa J, Devesa P, Sánchez Riolobos A. Factors Involved in the Functional Motor Recovery of Rats with Cortical Ablation after GH and Rehabilitation Treatment: Cortical Cell Proliferation and Nestin and Actin Expression in the Striatum and Thalamus. International Journal of Molecular Sciences. 20. PMID 31744113 DOI: 10.3390/ijms20225770   
2019 Alberquilla S, Gonzalez-Granillo A, Martin ED, Moratalla R. Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner. Neurobiology of Disease. 104666. PMID 31682992 DOI: 10.1016/j.nbd.2019.104666   
2019 Yan T, Sun Y, Gong G, Li Y, Fan K, Wu B, Bi K, Jia Y. The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway. Experimental Gerontology. 110743. PMID 31629801 DOI: 10.1016/j.exger.2019.110743   
2019 Xie W, Gao J, Jiang R, Liu X, Lai F, Tang Y, Xiao H, Jia Y, Bai Q. Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice. Neurotoxicology. PMID 31790727 DOI: 10.1016/j.neuro.2019.11.009   
2019 Saleem U, Raza Z, Anwar F, Chaudary Z, Ahmad B. Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson's disease. Bmc Complementary and Alternative Medicine. 19: 352. PMID 31805998 DOI: 10.1186/s12906-019-2772-5   
2019 Ma J, Yuan L, Wang SJ, Lei J, Wang Y, Li YN, Yu BL. [Electroacupuncture improved locomotor function by regulating expression of tyrosine hydroxylase and α-synuclein proteins and transcription activating factor 6 and transcription factor X box binding protein 1 mRNAs in substantia nigra of rats with Parkinson's disease]. Zhen Ci Yan Jiu = Acupuncture Research. 44: 805-9. PMID 31777229 DOI: 10.13702/j.1000-0607.180600   
2019 Andersen MA, Sotty F, Jensen PH, Badolo L, Jeggo R, Smith GP, Christensen KV. Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications. Eneuro. PMID 31685675 DOI: 10.1523/ENEURO.0453-18.2019   
2019 Rentsch P, Stayte S, Egan T, Clark I, Vissel B. Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia. Neurobiology of Disease. 104646. PMID 31669673 DOI: 10.1016/j.nbd.2019.104646